Intracellular IFNγ production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 121-127

  Toyoda, Mieko ^a   Pao, Andy ^a   Vo, Ashley ^a   Lukovsky, Marina ^a   Radha, Raju ^a   Sado, Tetsu ^a   Ge, Shili ^a   Reinsmoen, Nancy ^a   Chai, Ning Ning ^a   Baden, Lara ^a   Petrosyan, Anna ^a   Skinner, Edwina ^a   Mirocha, James ^a   Jordan, Stanley C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antibody mediated rejection; Flow cytometry; Interferon gamma; Monitoring; Sensitization

Indexed keywords

ALLOANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; HLA ANTIBODY; IMMUNOGLOBULIN G; HLA ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLOIMMUNITY; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL POPULATION; CELL STIMULATION; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DESENSITIZATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOASSAY; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SENSITIZATION; SEX DIFFERENCE; BIOSYNTHESIS; CELL COUNT; GRAFT REJECTION; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PREGNANCY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; CELL COUNT; CHILD; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREGNANCY; RISK FACTORS; SEX FACTORS;

EID: 77951628514     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.11.004     Document Type: Article

References (34)

1. Tyan D.B., Li V.A., Czer L., Trento A., Jordan S.C. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994, 57(4):553-562.
2. Jordan S.C., Tyan D., Stablein D., McIntosh M., Rose S., Vo A., et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004, 15(12):3256-3262.
3. Jordan S.C., Vo A.A., Peng A., Toyoda M., Tyan D. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 2006, 6(3):459-466.
4. Glotz D., Antoine C., Julia P., Pegaz-Fiornet B., Duboust A., Boudjeltia S., et al. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies. Transpl Int 2004, 17(1):1-8.
5. Glotz D., Antoine C., Julia P., Suberbielle-Boissel C., Boudjeltia S., Fraoui R., et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002, 2(8):758-760.
6. Montgomery R.A., Zachary A.A., Racusen L.C., Leffell M.S., King K.E., Burdick J., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000, 70(6):887-895.
7. Gloor J.M., DeGoey S., Ploeger N., Gebel H., Bray R., Moore S.B., et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004, 78(2):221-227.
8. Vieira C.A., Agarwal A., Book B.K., Sidner R.A., Bearden C.M., Gebel H.M., et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation 2004, 77(4):542-548.
9. Vo A.A., Toyoda M., Peng A., Bunnapradist S., Lukovsky M., Jordan S.C. Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG. Am J Transplant 2006, 6(10):2384-2390.
10. Akalin E., Bromberg J.S. Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients. Hum Immunol 2005, 66(4):359-363.
11. Reinsmoen N.L., Lai C.H., Vo A., Cao K., Ong G., Naim M., et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 2008, 86(6):820-825.
12. Vo A.A., Lukovsky M., Toyoda M., Wang J., Reinsmoen N.L., Lai C.H., et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008, 359(3):242-251.
13. Meier-Kriesche H.U., Ojo A.O., Hanson J.A., Cibrik D.M., Punch J.D., Leichtman A.B., et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000, 70(7):1098-1100.
14. Terasaki P.I., Cai J. Humoral theory of transplantation: further evidence. Curr Opin Immunol 2005, 17(5):541-545.
15. Rifle G., Mousson C., Martin L., Guignier F., Hajji K. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 2005, 79(3 Suppl):S14-S18.
16. Pescovitz M.D. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection. Clin Transplant 2006, 20(1):48-54.
17. Martin L., Guignier F., Mousson C., Rageot D., Justrabo E., Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003, 76(2):395-400.
18. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 2005, 19(Suppl 14):76-85.
19. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55(2):713-723.
20. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3(6):708-714.
21. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274(5284):94-96.
22. Radha R., Jordan S., Puliyanda D., Bunnapradist S., Petrosyan A., Amet N., et al. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant 2005, 5(1):110-117.
23. Nomura L.E., Walker J.M., Maecker H.T. Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells. Cytometry 2000, 40(1):60-68.
24. Toyoda M., Zhang X.M., Petrosian A., Wachs K., Moudgil A., Jordan S.C. Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin. Transpl Immunol 1994, 2(4):337-341.
25. Cohen J., Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences 1983, L. Erlbaum Associates, Hillsdale, N.J. 2nd ed.
26. Vongwiwatana A., Tasanarong A., Hidalgo L.G., Halloran P.F. The role of B cells and alloantibody in the host response to human organ allografts. Immunol Rev 2003, 196:197-218.
27. Mulder A., Kardol M.J., Kamp J., Uit Het Broek C., Schreuder G.M., Doxiadis I.I., et al. Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol 2001, 124(1):9-15.
28. Mulder A., Eijsink C., Kardol M.J., Franke-van Dijk M.E., van der Burg S.H., Kester M., et al. Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers. J Immunol 2003, 171(12):6599-6603.
29. Zachary A.A., Kopchaliiska D., Montgomery R.A., Leffell M.S. HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007, 83(7):982-988.
30. Poggio E.D., Augustine J.J., Clemente M., Danzig J.M., Volokh N., Zand M.S., et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007, 83(7):847-852.
31. Korin Y.D., Lee C., Gjertson D.W., Wilkinson A.H., Pham T.P., Danovitch G.M., et al. A novel flow assay for the detection of cytokine secreting alloreactive T cells: application to immune monitoring. Hum Immunol 2005, 66(11):1110-1124.
32. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22(11):633-640.
33. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457(7229):557-561.
34. O'Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006, 7(5):507-516.